Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by made2laston Sep 22, 2017 11:53am

90 Views

Post# 26731093

RE:RE:RE:RE:RE:RE:Nasopharyngeal carcinoma: Keytruda overall efficacy = 22%

Hi bencro;

I do agree with you, your assessment is quite accurate. And as always, thank you for your fine efforts to bring so much valuable information to the board. Truly appreciated.

As far as macman1519, he is on our side, he just ascribes to the philosophy that the squeaky wheel gets the oil. It is far better to hear a proactive squeaky long than putting up with the lies of bashers.

The best of luck to all longs;

made2last

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments